|
1.Alzheimer’s Disease International. World Alzheimer Report 2010. 2.Zhang, Y.W.; Thompson, R.; Zhang, H.; Xu, H. APP processing in Alzheimer’s disease. BioMed Central. 2011, 4:3 3.Goedert, M.; Spillantini, M. G. A century of Alzheimer's disease. Science 2006, 314, 777-781. 4.Jakob-Roetne, R.; Jacobsen, H. Alzheimer's disease: from pathology to therapeutic approaches. Angew. Chem. Int. Ed. Engl. 2009, 48, 3030-3059. 5.Kim, D.; Tsai, L.-H. Bridging physiology and pathology in AD. Cell 2009, 137, 997-1000. 6.Chiu, M. J.; Chen, T. F.; Yip, P. K.; Hua, M. S.; Tang, L.Y. Behavioral and psychologic symptoms in different types of dementia. J Formos Med Assoc. 2006, 105(7), 556-62. 7.Frisoni, G. B., Fox, N. C., Jack Jr, C. R., Scheltens, P., Thompson, P. M. The clinical use of structural MRI in Alzheimer disease. Nat. rev. 2010, 6, 67-77. 8.Elizabeth et al. Neuropsychological and neuroimaging changes in preclinical Alzheimer’s disease. J Int Neuropsychol Soc. 2006, 12, 707–735. 9.Perrin, R. J.; Fagan, A. M.; Holtzman, D. M. Multimodal techniques for diagnosis and prognosis of Alzheimer's disease. Nature 2009, 461, 916-22. 10.Blennow, K.; de Leon, M. J.; Zetterberg, H. Alzheimer’s disease. Lancet 2006; 368, 387–403. 11.Chiu, M. J.; Chen, T. F.; Yip, P. K.; Hua, M. S.; Tang, L.Y. Behavioral and psychologic symptoms in different types of dementia. J Formos Med Assoc. 2006, 105(7), 556-62. 12.Querfurth, H.; Laferla, F. Alzheimer's DiseaseMechanisms of Disease. N Engl J Med. 2010, 362, 329-344. 13.De Strooper, B.; Vassar, R.; Golde, T. The secretases: enzymes with therapeutic potential in Alzheimer disease. Nat. Rev. Neurol. 2010, 6, 99-107. 14.Roberson, E. D.; Mucke, L. 100 years and counting: prospects for defeating Alzheimer's disease. Science 2006, 314, 781-784. 15.Villemagne, V. L.; Cappai, R.; Barnham, K. J.; Cherny, R. A.; Opazo, C. The Aβcentric Pathway of Alzheimer's Disease. 2007.
|